Reversal of Severe and Refractory Humoral Hypercalcemia With 177Lu-Octreotate Peptide Receptor Radionuclide Therapy for Neuroendocrine Tumor of the Pancreas. (Record no. 24961873)
[ view plain ]
000 -LEADER | |
---|---|
fixed length control field | 01286 a2200337 4500 |
005 - DATE AND TIME OF LATEST TRANSACTION | |
control field | 20250517034651.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 201602s 0 0 eng d |
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
International Standard Serial Number | 1536-0229 |
024 7# - OTHER STANDARD IDENTIFIER | |
Standard number or code | 10.1097/RLU.0000000000000862 |
Source of number or code | doi |
040 ## - CATALOGING SOURCE | |
Original cataloging agency | NLM |
Language of cataloging | eng |
Transcribing agency | NLM |
100 1# - MAIN ENTRY--PERSONAL NAME | |
Personal name | Iliuta, Ioan-Andrei |
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
Date of production, publication, distribution, manufacture, or copyright notice | 20160223 |
245 00 - TITLE STATEMENT | |
Title | Reversal of Severe and Refractory Humoral Hypercalcemia With 177Lu-Octreotate Peptide Receptor Radionuclide Therapy for Neuroendocrine Tumor of the Pancreas. |
Medium | [electronic resource] |
260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
Name of publisher, distributor, etc. | Clinical nuclear medicine |
Date of publication, distribution, etc. | Sep 2015 |
300 ## - PHYSICAL DESCRIPTION | |
Extent | e448-50 p. |
Other physical details | digital |
500 ## - GENERAL NOTE | |
General note | Publication Type: Case Reports; Journal Article |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Humans |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Hypercalcemia |
General subdivision | etiology |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Male |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Middle Aged |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Neuroendocrine Tumors |
General subdivision | complications |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Octreotide |
General subdivision | analogs & derivatives |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Pancreatic Neoplasms |
General subdivision | complications |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Radiopharmaceuticals |
General subdivision | therapeutic use |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Beauregard, Jean-Mathieu |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Couture, Félix |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Douville, Pierre |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Mac-Way, Fabrice |
773 0# - HOST ITEM ENTRY | |
Title | Clinical nuclear medicine |
Related parts | vol. 40 |
-- | no. 9 |
-- | p. e448-50 |
856 40 - ELECTRONIC LOCATION AND ACCESS | |
Uniform Resource Identifier | <a href="https://doi.org/10.1097/RLU.0000000000000862">https://doi.org/10.1097/RLU.0000000000000862</a> |
Public note | Available from publisher's website |
No items available.